An Act Requiring Health Insurance Coverage For Fertility Preservation For Cancer Patients.
Impact
By requiring coverage for fertility preservation, HB 5245 would amend existing insurance regulations to ensure that cancer patients have access to necessary reproductive health services. The bill provides specific guidelines regarding the age limit for coverage and lifetime benefits for procedures, recognizing the need to balance comprehensive health support for patients with insurance cost considerations. Nonetheless, it does exclude coverage for the storage of embryos, oocytes, or sperm, which may pose a financial burden on patients after the initial procedures.
Summary
House Bill 5245 mandates health insurance coverage for fertility preservation procedures, specifically embryo, oocyte, and sperm cryopreservation, for cancer patients who have been diagnosed but have not yet begun treatment. This requirement applies to individual and group health insurance policies in Connecticut and is set to take effect on January 1, 2015. The bill aims to support individuals diagnosed with cancer, enabling them to preserve their fertility as a proactive measure before embarking on potentially fertility-impacting treatments such as chemotherapy or radiation therapy.
Sentiment
The sentiment surrounding HB 5245 appears to be largely positive among healthcare advocates and cancer support groups who view this legislation as a significant step toward ensuring reproductive health rights for cancer patients. However, concerns regarding the limits placed on coverage, such as age caps and lifetime limits for procedures, indicate a need for continued dialogue about policy enhancements that fully support patients' long-term reproductive health needs. The potential financial implications may also remain a point of contention among stakeholders.
Contention
Notable points of contention include the limitations imposed on the number of procedures covered and age restrictions for eligibility, which some argue may prevent equitable access to fertility preservation services for all cancer patients. Additionally, the exclusion of storage costs has raised concerns about the affordability of long-term fertility preservation solutions, especially for individuals who wish to utilize the preserved options later in life. These discussions highlight the ongoing debate about the scope and balance of healthcare coverage in areas significantly impacting patient quality of life.
An Act Prohibiting Certain Health Carriers From Requiring Step Therapy For Prescription Drugs Used To Treat A Mental Or Behavioral Health Condition Or A Chronic, Disabling Or Life-threatening Condition.
An Act Concerning Insurance Market Conduct And Insurance Licensing, The Insurance Department's Technical Corrections And Other Revisions To The Insurance Statutes And Captive Insurance.
Requesting The Auditor To Assess The Social And Financial Effects Of Mandatory Health Insurance Coverage For Fertility Preservation Procedures For Certain Persons Who Have Been Diagnosed With Cancer And Whose Cancer Or Cancer Treatment May Adversely Affect Their Fertility.
Requesting The Auditor To Assess The Social And Financial Effects Of Mandatory Health Insurance Coverage For Fertility Preservation Procedures For Certain Persons Who Have Been Diagnosed With Cancer And Whose Cancer Or Cancer Treatment May Adversely Affect Their Fertility.